This Presolicitation opportunity from Department Of Veterans Affairs was posted on February 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6835--NOTICE OF INTENT TO SOLE SOURCE Inhales Nitric-Oxide Gas WEST HAVEN VAMC

Closed

36C24126Q0240Federal

Submission Closed02/12/2026, 10:00:00 AM EST

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

International

Compounded Antimicrobial Homecare Supply and ServiceThe Compounded Antimicrobial Homecare Supply and Service subcontract, issued by the Leeds Teaching Hospitals NHS Trust, involves the production and supply chain management of unlicensed compounded antimicrobial medicines. The selected provider will utilize specialized pharmaceutical compounding facilities to prepare these agents and manage the delivery process for patients within the NEY region as part of NEYPPC High Tech Homecare projects. To qualify, the provider must hold the necessary pharmaceutical manufacturing licenses and maintain strict adherence to NHS and NEYPPC homecare standards. The scope of work encompasses both the delivery of the compounded medications and the provision of essential homecare support services to ensure patient safety and treatment efficacy.

Leeds Teaching Hospitals NHS Trust

POSTED

DEADLINE

Compounded Desferrioxamine Homecare Supply and ServiceThis subcontract, titled Compounded Desferrioxamine Homecare Supply and Service, is issued by the Leeds Teaching Hospitals NHS Trust. The selected provider will be responsible for the compounding of unlicensed Desferrioxamine medicines within specialized pharmaceutical facilities and the subsequent management of the high-tech supply chain to ensure delivery to patients within the NEY region. This role involves supporting prime contractors on NEYPPC High Tech Homecare projects by providing both the compounded medications and necessary homecare support services. To qualify for this contract, the provider must hold the required pharmaceutical manufacturing licenses and maintain strict adherence to NHS and NEYPPC homecare standards. The opportunity was posted on November 13, 2026, with a response deadline of November 16, 2026. The work falls under NAICS code 325412, focusing on the specialized production and distribution of pharmaceutical products for home-based patient care.

Leeds Teaching Hospitals NHS Trust

POSTED

DEADLINE

Hydrogen Peroxide Topical Solution SupplierThis subcontract involves the supply of 3% strength Hydrogen Peroxide Topical Solution for prime contractors supporting Department of Defense projects under the Medical Supply Chain Pharm FSA. The supplier is responsible for manufacturing or sourcing the liquid solution in 4-ounce bottles, delivered in cases of 24. Strict quality and storage requirements are mandated, including maintaining a temperature between 20 and 25 degrees Celsius and ensuring a minimum shelf life of 21 months upon receipt. The contractor must adhere to OTC pharmaceutical standards, the Buy American Act, the Berry Amendment, and Medical Marking Standard No. 1. Performance for this contract is centered in Fort Hood, Texas, under NAICS code 325412. Interested parties must have responded by the deadline of November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Permethrin Cream Rinse SupplyThis subcontract opportunity is for the manufacture or sourcing of pharmaceutical grade Permethrin Cream Rinse, identified by NSN 6505012564972, to support prime contractors on Department of Defense projects under the DLA Troop Support Medical Supply Chain Pharm FSA. The selected provider must possess a valid Unique Entity Identifier and CAGE code to be eligible. All products must be delivered in suitable sealed unit containers designed to prevent damage or breakage during transport. The project is categorized under NAICS code 325412 and will be performed at Fort Hood, Texas. Interested parties must submit their responses by November 18, 2026, following the posting date of November 12, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Pad Supply (NSN 6510-01-047-5619)This subcontract involves the manufacture or sourcing of medical pads under NSN 6510-01-047-5619 to support prime contractors on DLA Troop Support Medical Supply Chain projects for the Department of Defense. The requirement specifies the delivery of three jars, each containing 40 units, to a government destination in FPO 96663. All shipments must be marked and labeled in accordance with MIL-STD-129. Critical quality and timing constraints include a mandatory 36-month shelf life for the products and a delivery window within five months of the date of manufacture. The opportunity is categorized under NAICS code 325412, with a response deadline set for November 18, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Norgestrel and Ethinyl Estradiol TabletsThis subcontract involves the supply of USP-grade Norgestrel and Ethinyl Estradiol tablets to support prime contractors for the Department of Defense Medical Supply Chain. The contractor is responsible for manufacturing or sourcing tablets of domestic origin that strictly adhere to United States Pharmacopeia standards, utilizing compliant manufacturing and packaging facilities. The specific requirement is for the delivery of 1,000 PG of tablets as outlined in the CLIN 0001 specifications. Managed by the Medical Supply Chain Pharm FSA under NAICS code 325412, the performance of this contract is centered in Fort Hood, Texas. Interested parties must adhere to the timeline established by the posting date of November 12, 2026, with a response deadline set for November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Salicylic Acid Gel SupplierThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA requires the provision of 12,000 tubes of medical-grade Salicylic Acid Gel with a 17 percent concentration. Each tube must contain 0.25 ounces of the gel and be manufactured or sourced to meet strict storage and transport requirements at medical controlled room temperature. The supplier must ensure all products adhere to Medical Marking Standard No. 1 and follow packaging guidelines established by MIL-STD-129 and MIL-STD-2073-1E. Additionally, all shipments must include hazard warning labels in compliance with 252.223-7001 to support prime contractors delivering essential medical supplies to DLA Troop Support.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Surgical Detergent (Chlorhexidine Gluconate) SupplierThis subcontract involves the manufacture and supply of 4% Chlorhexidine Gluconate surgical detergent in 8 oz bottles for prime contractors supporting the Department of Defense Medical Supply Chain Pharmacy FSA. The supplier must strictly adhere to DLA Technical and Quality Requirements RA001 and Packaging Requirements RP001. A critical quality standard is the maintenance of a 24-month shelf life, with a minimum of 21 months remaining at the time of delivery to specified destinations. The contract is categorized under NAICS code 325412 and is associated with performance in Fort Hood, Texas. Interested parties should note the posting date of November 12, 2026, with a response deadline of November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Citalopram Hydrobromide Tablet ProductionThis subcontract involves the production and supply of Citalopram Hydrobromide 20 MG tablets to support prime contractors under Defense Logistics Agency supply contracts. The Department of Defense, specifically the Medical Supply Chain Pharm FSA, requires the tablets to be manufactured in FDA-approved facilities and delivered in sealed unit containers of 100 count. Performance for this contract is designated for Fort Stewart. The provider must ensure strict adherence to the Buy American Act, the Berry Amendment, and all DLA Technical and Quality Requirements. This procurement falls under NAICS code 325412, with a response deadline set for November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Powder Supply (NSN 6505-01-6711859)This subcontract involves the supply of medical powder, identified by NSN 6505-01-6711859, to support prime contractors for the Department of Defense under the DLA Troop Support Medical Supply Chain Pharm FSA. The requirement consists of 10 cases delivered FOB Destination to Fort Stewart, Georgia. Each case must contain 12 packets of 400g pouches. Strict adherence to technical and safety standards is required, including packaging per ASTM D3951 and labeling according to Medical Marking Standard 1C. Because the material is classified as hazardous, the provider must comply with FED-STD-313, TQ requirement IP025, and 29 CFR 1910.1200. The project falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Famotidine Tablets SupplyThis subcontract involves the supply of pharmaceutical-grade Famotidine 20 MG tablets to prime contractors for delivery to the Defense Logistics Agency under the Medical Supply Chain Pharm FSA. The tablets must adhere to specific standards based on Pepcid 20 MG and be delivered in 30-count bottles. All products must be FDA-regulated and accompanied by Safety Data Sheets and labeling that comply with 29 CFR 1910.1200. Shipments must be packaged and marked according to RP001 DLA Packaging Requirements and Medical Marking Standard No. 1. The place of performance for this contract is Joint Base Lewis McChord. Interested parties should note the response deadline of November 18, 2026, for this Department of Defense requirement categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Emollient Lotion Manufacturer/SupplierThis subcontract opportunity with the Department of Defense Medical Supply Chain Pharm FSA seeks a manufacturer to supply homogeneous, non-sterile emollient lotion for prime contractors on DLA Troop Support medical supply contracts. The supplier must be capable of formulating oil-in-water or water-in-oil emulsions consisting of water, oil, emulsifier, and preservative, while ensuring the final product maintains a pH between 5.0 and 8.1 and a viscosity of 10,000 to 20,000 CPS. To meet these technical specifications, the contractor is required to utilize industrial emulsification equipment and a quality control laboratory for rigorous testing. The contract involves the delivery of 15 bottles of the specified lotion and requires strict adherence to the Buy American and Balance of Payments Program. Performance will take place in Williamsburg, Virginia. Interested parties should note the response deadline of November 18, 2026, for this requirement categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days

General Info

Agency

Department Of Veterans Affairs → 241-NETWORK Contract Office 01 (36C241)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Set-Aside

NONE

Documents

3 pages · special-notice

Low

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedFeb 5

special-notice

Response DeadlineFeb 12

Deadline has passed

Submission Closed

02/12/2026, 10:00:00 AM EST

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 241-NETWORK Contract Office 01 (36C241)

Contacts1 person available

OfficeTOGUS, ME, 04330, USA

Organization / AgencyDepartment Of Veterans Affairs → 241-NETWORK Contract Office 01 (36C241)

Office AddressTOGUS, ME, 04330, USA

Contacts

Phillip CrockettContract Officer

Full Description

STATEMENT OF WORK (SOW) 1. Contract Title. INO Therapeutics 2. Background. The therapeutic use of inhaled nitric oxide is based on its ability to achieve potent and sustained pulmonary vasodilation, without significantly decreasing systemic vascular tone. 3. Place of Performance/Place of Delivery VA Connecticut Healthcare System 950 Campbell Ave. West Haven, CT 06516 Bldg. 1 2nd floor Room 2154 4. Scope. Patients of all ages who are undergoing or have undergone heart surgery and develop pulmonary hypertension. In these patients, INOmax is used to help improve heart function and reduce blood pressure in the lungs. The active substance in INOmax, nitric oxide, is a naturally occurring chemical in the body, which causes the muscles in the lining of the blood vessels to relax. When inhaled, it causes the vessels in the lungs to dilate (widen): this allows blood to flow more easily in the lungs to supply oxygen to the rest of the body and remove carbon dioxide, reducing pulmonary hypertension. It also helps to decrease inflammation in the lungs. It is a vasodilator, which, in conjunction with ventilator support and other appropriate agents, is indicated for the improvement of peri-operative pulmonary hypertension associated with heart surgery. INO selectively decreases pulmonary arterial pressure and improves right ventricular function and oxygenation. INO is already on-site at VACT and is used in the catheterization lab, intensive care units and operating rooms. 5. Specifications. Following requirements must exist for INO to function properly: Complete INOmax DSIR machine with associated parts. INO gas cylinders (800PPM) Calibrations gases NO and NO2 Backup INO blender INO tanks checked and replaced by manufacturer monthly. Recommended vendor Mallinckrodt Pharmaceuticals: Supplies the INO tank, machine for use and disposables needed for INO to be used. 6. Installation: None required, INO is on-site at VACT. 7. Period of Performance. Vendor shall deliver items and check tanks monthly.